DK241385A - Rekombinant lymphotoxin - Google Patents

Rekombinant lymphotoxin Download PDF

Info

Publication number
DK241385A
DK241385A DK241385A DK241385A DK241385A DK 241385 A DK241385 A DK 241385A DK 241385 A DK241385 A DK 241385A DK 241385 A DK241385 A DK 241385A DK 241385 A DK241385 A DK 241385A
Authority
DK
Denmark
Prior art keywords
recombinant lymphotoxin
lymphotoxin
recombinant
Prior art date
Application number
DK241385A
Other languages
English (en)
Other versions
DK241385D0 (da
DK171531B1 (da
Inventor
Bharat Bhushan Aggarwal
Timothy Schot Bringman
Patrick William Gray
Glenn Evan Nedwin
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/616,502 external-priority patent/US4959457A/en
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of DK241385D0 publication Critical patent/DK241385D0/da
Publication of DK241385A publication Critical patent/DK241385A/da
Priority to DK56995A priority Critical patent/DK172382B1/da
Application granted granted Critical
Publication of DK171531B1 publication Critical patent/DK171531B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/241—Tumor Necrosis Factors
    • C07K16/242—Lymphotoxin [LT]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/525—Tumour necrosis factor [TNF]
    • C07K14/5255—Lymphotoxin [LT]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/241—Tumor Necrosis Factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DK241385A 1984-05-31 1985-05-30 Isoleret biologisk aktivt humant lymphotoxinderiv at og antistof som neutraliserer den cytolytiske aktivitet af dette, nucleinsyre som koder for lymphotoxinderivatet, replikerbar vektor omfattende nucleinsyren, heterolog celle transformeret med nucleinsyren og fremgangsmåde som omfatter fremstilling af lymphotoxinderivatet. DK171531B1 (da)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DK56995A DK172382B1 (da) 1984-05-31 1995-05-18 Rekombinante lymphotoxinderivater

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US61650384A 1984-05-31 1984-05-31
US06/616,502 US4959457A (en) 1984-05-31 1984-05-31 Anti-lymphotoxin
US61650284 1984-05-31
US61650384 1984-05-31
US73231285A 1985-05-09 1985-05-09
US73231285 1985-05-09

Publications (3)

Publication Number Publication Date
DK241385D0 DK241385D0 (da) 1985-05-30
DK241385A true DK241385A (da) 1985-12-01
DK171531B1 DK171531B1 (da) 1996-12-23

Family

ID=27417179

Family Applications (1)

Application Number Title Priority Date Filing Date
DK241385A DK171531B1 (da) 1984-05-31 1985-05-30 Isoleret biologisk aktivt humant lymphotoxinderiv at og antistof som neutraliserer den cytolytiske aktivitet af dette, nucleinsyre som koder for lymphotoxinderivatet, replikerbar vektor omfattende nucleinsyren, heterolog celle transformeret med nucleinsyren og fremgangsmåde som omfatter fremstilling af lymphotoxinderivatet.

Country Status (23)

Country Link
EP (2) EP0509553B1 (da)
JP (3) JP2521703B2 (da)
AR (1) AR245219A1 (da)
AT (2) ATE95243T1 (da)
AU (1) AU599303B2 (da)
BG (1) BG60256B2 (da)
CA (1) CA1340641C (da)
CZ (1) CZ283148B6 (da)
DE (2) DE3587597T2 (da)
DK (1) DK171531B1 (da)
ES (1) ES8802182A1 (da)
FI (1) FI93025C (da)
GR (1) GR851317B (da)
HU (1) HU204085B (da)
IE (1) IE63487B1 (da)
IL (1) IL75318A (da)
NO (1) NO179075C (da)
NZ (1) NZ212207A (da)
PL (1) PL155410B1 (da)
PT (1) PT80573B (da)
RO (1) RO100383A2 (da)
SK (1) SK393085A3 (da)
YU (1) YU47735B (da)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3177213D1 (de) 1980-04-03 1990-10-18 Biogen Inc Dns-sequenzen, rekombinante dns-molekuele und verfahren zur herstellung von dem menschlichen fibroblast-interferon.
US5683688A (en) * 1984-05-31 1997-11-04 Genentech, Inc. Unglycosylated recombinant human lymphotoxin polypeptides and compositions
NZ212207A (en) 1984-05-31 1991-07-26 Genentech Inc Recombinant lymphotoxin
IL73883A (en) * 1984-12-20 1990-12-23 Yeda Res & Dev Monoclonal antibodies against tnf-alpha,hybridomas producing them and method for the purification of tnf-alpha
JP2557053B2 (ja) * 1984-12-21 1996-11-27 バイオジェン インコーポレイテッド 腫瘍壊死因子の精製、製造および使用法
AU603768B2 (en) * 1985-07-04 1990-11-29 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Lymphotoxin dna, lymphotoxin expression vector, lymphotoxin resistant cell, transformant with lymphotoxin expression vector and process for preparing lymphotoxin
JPS62195285A (ja) * 1986-02-19 1987-08-28 Kanegafuchi Chem Ind Co Ltd リンホトキシン発現ベクタ−及びそれを用いるリンホトキシンの製造方法
JPS62111928A (ja) * 1985-10-15 1987-05-22 Kanegafuchi Chem Ind Co Ltd 新規リンホトキシン
DE3686148T2 (de) * 1985-12-24 1993-01-14 Denki Kagaku Kogyo Kk Lymphotoxin-gen, verfahren zu dessen herstellung und lymphotoxin.
US5403725A (en) * 1985-12-24 1995-04-04 Denki Kagaku Kogyo Kabushiki Kaisha Method for production of lymphotoxin (TNFB) in cell line A-C5-8
JP2548204B2 (ja) * 1987-06-27 1996-10-30 電気化学工業株式会社 新生理活性ポリペプチド
EP0230574A3 (en) * 1986-01-31 1989-03-22 Yale University Pharmaceutical compositions against infections caused by lav/htlv iii virus and the use thereof
JPS62181298A (ja) * 1986-02-05 1987-08-08 Kyowa Hakko Kogyo Co Ltd ヒトリンホトキシンポリペプチド誘導体
DE3620656A1 (de) * 1986-06-20 1987-12-23 Basf Ag Polypeptide mit lymphotoxin-aktivitaet oder lymphotoxin-aehnlicher aktivitaet, ihre herstellung und verwendung
JPS63105680A (ja) * 1986-10-22 1988-05-10 Kanegafuchi Chem Ind Co Ltd ヒト・リンホトキシン発現ベクタ−、該発現ベクタ−による形質転換細胞および該細胞を用いるリンホトキシンの製造方法
US5175268A (en) * 1986-12-24 1992-12-29 Takeda Chemical Industries, Ltd. DNA encoding recombinant human lymphotoxin
EP0272894A3 (en) * 1986-12-24 1989-06-14 Takeda Chemical Industries, Ltd. Recombinant human lymphotoxin
FI884798A7 (fi) * 1987-10-28 1989-04-29 Eisai Co Ltd Rekombinantlymfotoxin.
DE3837012A1 (de) * 1988-01-15 1989-07-27 Knoll Ag Verwendung von tnf und lt zur herstellung von arzneimitteln
GB2217326B (en) * 1988-04-08 1991-11-20 British Bio Technology Synthetic gene encoding human tumour necrosis factor beta.
EP0338497A3 (en) * 1988-04-22 1990-05-16 Takeda Chemical Industries, Ltd. Bispecific hybrid monoclonal antibody
JPH023698A (ja) * 1988-06-20 1990-01-09 Denki Kagaku Kogyo Kk ヒトリンホトキシンに対するモノクローナル抗体及びそれら抗体を産生するハイブリドーマ、並びにそれら抗体を用いたヒトリンホトキシンの精製方法、測定方法及び測定試薬
CA2001756A1 (en) * 1988-10-31 1991-04-30 Seiichi Uesugi New human lymphotoxin n-end deletion mutant
JPH03106821A (ja) * 1989-09-20 1991-05-07 Denki Kagaku Kogyo Kk 抗腫瘍剤
US5200176A (en) * 1989-10-06 1993-04-06 Genentech, Inc. Method for protection of ischemic tissues using tumor nerosis factor
US5370870A (en) * 1989-10-06 1994-12-06 Genentech, Inc. Method for protection against reactive oxygen species
IL97779A (en) * 1990-04-10 2000-01-31 Genentech Inc Compositions for cytoprotection against radiation and chemotherapy injury or risk thereof
US5747023A (en) * 1994-07-01 1998-05-05 Genentech, Inc. Cancer therapy using lymphotoxin
KR100528604B1 (ko) * 1995-01-23 2006-03-16 제노테크 인코포레이티드 골용해와전이를개선하기위한조성물
US5925351A (en) 1995-07-21 1999-07-20 Biogen, Inc. Soluble lymphotoxin-β receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological disease
US6998116B1 (en) 1996-01-09 2006-02-14 Genentech, Inc. Apo-2 ligand
EP1045906B1 (en) 1998-01-15 2008-10-15 Genentech, Inc. Apo-2 ligand
JP2011516026A (ja) * 2002-11-26 2011-05-26 ジェネンテック・インコーポレーテッド 免疫関連疾患の治療のための組成物と方法
US7700097B2 (en) 2003-06-27 2010-04-20 Biogen Idec Ma Inc. Purification and preferential synthesis of binding molecules
WO2005067477A2 (en) * 2003-12-08 2005-07-28 Centocor, Inc. Anti-human lymphotoxin alpha antibodies, compositions, methods and uses
BRPI0509201A (pt) 2004-03-23 2007-08-28 Biogen Idec Inc agentes de acoplamento de receptor e usos terapêuticos destes
WO2006074399A2 (en) 2005-01-05 2006-07-13 Biogen Idec Ma Inc. Multispecific binding molecules comprising connecting peptides
NZ576032A (en) * 2006-10-12 2012-03-30 Genentech Inc Antibodies to lymphotoxin-alpha
SG178002A1 (en) 2006-10-20 2012-02-28 Biogen Idec Inc Treatment of demyelinating disorders
US8338376B2 (en) 2006-10-20 2012-12-25 Biogen Idec Ma Inc. Compositions comprising variant LT-B-R-IG fusion proteins
KR20160144499A (ko) * 2014-04-25 2016-12-16 노렉스, 인크. 신경활성 펩타이드의 안정한 조성물

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK171727B1 (da) * 1978-12-22 1997-04-14 Biogen Inc Rekombinante hepatitis B virus DNA-molekyler, værtsorganismer transformeret hermed, HBV-antigenspecifikke polypeptider, DNA-sekvenser kodende for HBV-antigenspecifikke polypeptider, metoder til påvisning af hepatitis B virus-antistoffer, metoder til fremstilling af nævnte DNA-molekyler, fremgangsmåder til fremstilling af nævnte polypeptider og midler til påvisning af HBV-infektion
NZ201918A (en) 1981-09-18 1987-04-30 Genentech Inc N-terminal methionyl analogues of bovine growth hormone
ZA834976B (en) * 1982-07-30 1984-08-29 Genentech Inc Human lymphotoxin
FI82266C (fi) 1982-10-19 1991-02-11 Cetus Corp Foerfarande foer framstaellning av il-2 -mutein.
EP0135797A3 (de) * 1983-08-30 1987-11-11 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Verfahren zur Herstellung von Lymphotoxin und von Lymphotoxin-mRNA
DE3331108A1 (de) * 1983-08-30 1985-05-02 Boehringer Ingelheim International GmbH, 6507 Ingelheim Verfahren zur herstellung von lymphotoxin und von lymphotoxin-mrna
NZ212207A (en) 1984-05-31 1991-07-26 Genentech Inc Recombinant lymphotoxin

Also Published As

Publication number Publication date
AU4320385A (en) 1985-12-05
BG60256B1 (bg) 1994-03-24
RO100383B1 (ro) 1991-03-01
FI852143A0 (fi) 1985-05-29
FI93025B (fi) 1994-10-31
DE3587597T2 (de) 1994-06-01
ES543695A0 (es) 1988-04-16
PT80573B (pt) 1987-08-19
ATE195323T1 (de) 2000-08-15
IE63487B1 (en) 1995-05-03
ES8802182A1 (es) 1988-04-16
AR245219A1 (es) 1993-12-30
HU204085B (en) 1991-11-28
DK241385D0 (da) 1985-05-30
JPS6156197A (ja) 1986-03-20
EP0164965B1 (en) 1993-09-29
NO852173L (no) 1985-12-02
FI93025C (fi) 1995-02-10
NO179075C (no) 1996-07-31
IE851321L (en) 1985-11-30
EP0164965A2 (en) 1985-12-18
IL75318A (en) 1994-08-26
YU91985A (en) 1988-12-31
BG60256B2 (bg) 1994-03-24
SK278333B6 (en) 1996-11-06
NZ212207A (en) 1991-07-26
DE3588225T2 (de) 2001-04-05
SK393085A3 (en) 1996-11-06
EP0509553A1 (en) 1992-10-21
JPH07250692A (ja) 1995-10-03
PL253739A1 (en) 1986-03-11
CZ283148B6 (cs) 1998-01-14
RO100383A2 (ro) 1991-10-17
HUT37814A (en) 1986-02-28
JPH07291995A (ja) 1995-11-07
JP2804237B2 (ja) 1998-09-24
DE3587597D1 (de) 1993-11-04
DE3588225D1 (de) 2000-09-14
GR851317B (da) 1985-11-25
PL155410B1 (en) 1991-11-29
PT80573A (en) 1985-06-01
DK171531B1 (da) 1996-12-23
CZ393085A3 (en) 1997-07-16
ATE95243T1 (de) 1993-10-15
CA1340641C (en) 1999-07-13
YU47735B (sh) 1996-01-08
EP0509553B1 (en) 2000-08-09
EP0164965A3 (en) 1988-04-06
FI852143L (fi) 1985-12-01
IE930589L (en) 1985-11-30
JP2521703B2 (ja) 1996-08-07
NO179075B (no) 1996-04-22
IL75318A0 (en) 1985-09-29
AU599303B2 (en) 1990-07-19

Similar Documents

Publication Publication Date Title
DK241385D0 (da) Rekombinant lymphotoxin
DK552285A (da) Proteinkonjugat
DK184485A (da) Mejetaersker
DE3683186D1 (de) Rekombinantes humaninterleukin-1.
FR2571818B1 (fr) Raccord auto-obturateur
DK383985A (da) Polypeptid
DK256385D0 (da) Interferonpraeparat
NO170503C (no) Broennhull-proevetaker
FR2569073B1 (fr) Magnetoscope numerique
DK446085D0 (da) Triazol- eller imidazolfungicidholdige materialer
ES530597A0 (es) Polipeptido de interferon- humano
FR2563962B3 (fr) Interceps perfectionne
FR2573843B1 (fr) Raccord
FI840579A0 (fi) Pipett med reglerbar volym
FI852866A0 (fi) Rekombinantfaktor viii-r.
FI884798A7 (fi) Rekombinantlymfotoxin.
IL104297A0 (en) Recombinant lymphotoxin
KR850008429U (ko) 도마
DK51585A (da) Proteinkoncentrater
DK8884D0 (da) Polypeptider
SE8405895D0 (sv) Konstruktionselement
SE8405843D0 (sv) Konstruktionselement
ES279666Y (es) Marquesina
SE8401043D0 (sv) Markiskonstruktion
ES278178Y (es) Cuelga-escobas mejorado

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PUP Patent expired